Hematology-Oncology Clinics of North America

Article	Citations
Epidemiology of Melanoma	45
The Clinical Management of Clonal Hematopoiesis	42
Biology of Melanoma	40
Molecular Pathogenesis of Mantle Cell Lymphoma	38
Factor XI Deficiency	32
Screening for Colorectal Cancer	29
Diagnosis and Staging of Bladder Cancer	27
The Epidemiology of Bladder Cancer	24
Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus	22
Epidemiology of Follicular Lymphoma	22
Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm	19
Lip and Oral Cavity Squamous Cell Carcinoma	18
Current Role and Emerging Evidence for Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma	17
Blastoid Mantle Cell Lymphoma	17
CD123 as a Therapeutic Target Against Malignant Stem Cells	17
Overview of Myeloproliferative Neoplasms	17
Disorders of Fibrinogen and Fibrinolysis	16
Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice	16
Luspatercept in Myelodysplastic Syndromes	15
Secondary Acute Myeloid Leukemia	15
Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm	14
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms	14
Blastic Plasmacytoid Dendritic Cell Neoplasm in Children	14
The Epidemiology of Central Nervous System Tumors	14
Blastic Plasmacytoid Dendritic Cell Neoplasm	13

Targeting TP53 Mutations in Myelodysplastic Syndromes	13
Genetics of Myeloproliferative Neoplasms	13
Colorectal Cancer in Younger Adults	12
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer	12
Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm	12
Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm	12
Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm	12
Acquired von Willebrand Syndrome	12
The Role of Megakaryocytes in Myelofibrosis	12
Cellular Therapy and Cytokine Treatments for Melanoma	11
Von Willebrand Disease	11
The Microenvironment in Myeloproliferative Neoplasms	11
Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II)	11
Prospects for Venetoclax in Myelodysplastic Syndromes	11
Current Clinical Investigations in Myelofibrosis	11
Hereditary Colorectal Cancer	11
Acquired Hemophilia A	10
Targeting Aberrant Splicing in Myelodysplastic Syndromes	10
Impact of Diet and Exercise on Colorectal Cancer	10
Central Nervous System Metastases	10
Primary Central Nervous System Lymphomas	10
Minimal Residual Disease in Mantle Cell Lymphoma	9
Pancreatic Adenocarcinoma	9
Developing Precision Medicine for Bladder Cancer	9
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	9
Managing Recurrent Metastatic Head and Neck Cancer	9
Gene Therapy for Hemoglobinopathies	9
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?	8
Salivary Gland Cancers	8
Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm	8
Systemic Amyloidosis due to Low-Grade Lymphoma	8
Factor XIII Deficiency	8
Monoclonal Antibody Therapies in Systemic Light-Chain Amyloidosis	8
The Process of Amyloid Formation due to Monoclonal Immunoglobulins	8
Go the Distance	7
Cancer of the Paranasal Sinuses	7
Hemophilia A (Factor VIII Deficiency)	7
Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis	7
Immunotherapy for Head and Neck Cancer	7
Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia	7
Gene Therapy and Gene Editing for β-Thalassemia	7
Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors	7
Systemic Amyloidosis Due to Clonal Plasma Cell Diseases	7
Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms	7
Neurofibromatoses	7
Cancer of the Larynx and Hypopharynx	7
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	6
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia	6
Do Recent Randomized Trial Results Influence which Patients with Myelodysplastic Syndromes Receive Iron Chelation?	6
Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma	6

The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia	6
Adult Evans' Syndrome	6
Application of Stem Cell Therapy in Myelofibrosis	6
The Clinical Phenotypes of Alpha Thalassemia	6
Management of Rectal Cancer	6
A Curative DNA Code for Hematopoietic Defects	6
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer	5
Update on Radiation Therapy for Central Nervous System Tumors	5
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	5
The Biological Basis of Histologic Transformation	5
Liver and Gastrointestinal Involvement	5
Preclinical Models for Bladder Cancer Research	5
Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	5
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	5
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology	5
Real World Outcomes of Patients with Bladder Cancer	5
Advanced Melanoma	5
Immune Therapy for Chronic Lymphocytic Leukemia	5
Gene Therapy for Inborn Errors of Immunity	5
Disparities and Inequities Among Patients with Central Nervous System Tumor	5
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art	5
Hemophilia B (Factor IX Deficiency)	5
Is There a Role for Immunotherapy in Central Nervous System Cancers?	5
Combinatorial Approaches to the Treatment of Advanced Melanoma	5
Immunotherapy-associated Autoimmune Hemolytic Anemia	4
Approach to the Initial Treatment of Older Patients with Mantle Cell Lymphoma	4
Genetic Modifiers of Sickle Cell Disease	4
Molecular Biology of Bladder Cancer	4
State of Melanoma	4
Blastic Plasmacytoid Dendritic Cell Neoplasm	4
Epigenetic Dysregulation of Myeloproliferative Neoplasms	4
Quality of Life in Sickle Cell Disease	4
Molecular Basis and Genetic Modifiers of Thalassemia	4
Current Therapy for Metastatic Urothelial Carcinoma	4
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	4
Hematopoietic Stem Cell Transplantation in Thalassemia	4
Immune Checkpoint Therapies for Melanoma	4
Accelerated and Blast Phase Myeloproliferative Neoplasms	4
Renal Cell Carcinoma of Variant Histology	4
Chimeric Antigen Receptor T-cell Therapy	4
Surgical Management of the Axilla for Breast Cancer	4
Nonoperative Management for Rectal Cancer	4
Evolution of Gene Therapy, Historical Perspective	4
Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm	4
Quality of Life in Myeloproliferative Neoplasms	4
Novel Prognostic Models for Myelodysplastic Syndromes	4
Structural Racism and Impact on Sickle Cell Disease	4
Systemic Amyloidosis due to Monoclonal Immunoglobulins	4
Watch and Wait in Mantle Cell Lymphoma	4
Robotic and Endoscopic Approaches to Head and Neck Surgery	4
Treatment of Histologic Transformation	4
Cell Cycle Dysregulation in Mantle Cell Lymphoma	4
Future Perspectives	4
Emerging Targeted Therapy for Bladder Cancer	4
Emerging Therapies in β-Thalassemia	4
Extracutaneous Melanoma	3
Cancer of the Oropharynx and the Association with Human Papillomavirus	3
Fetal Hemoglobin Regulation in Beta-Thalassemia	3
Updates in the Management of Warm Autoimmune Hemolytic Anemia	3
Treatment of Acquired Sideroblastic Anemias	3
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia	3
Role of Ovarian Suppression in Early Premenopausal Breast Cancer	3
Liver and Gastrointestinal Involvement	3
Local Therapies in Advanced Colorectal Cancer	3
Surgery for Bladder and Upper Tract Urothelial Cancer	3
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?	3
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer	3
Clinical Challenges with Iron Chelation in Beta Thalassemia	3
Red Cell Antigens and Antibodies	3
Imaging Advances for Central Nervous System Tumors	3
Immunotherapy and Immunomodulation in Myeloproliferative Neoplasms	3
Chronic Pain	3
Supportive Care for Patients with Systemic Light Chain Amyloidosis	3
Clinical and Biological Prognostic Factors in Follicular Lymphoma	3
Biology and Treatment of Meningiomas	3
Evidence-Based Guidance for Breast Cancer Survivorship	2
The Impact of AL Amyloidosis	2
The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia	2
Pathogenic Mechanisms in Thalassemia II	2
Management of Brain Metastases in Metastatic Renal Cell Carcinoma	2

Solid Organ Transplantation	2
Antibody Therapy Maintenance in Follicular Lymphoma	2
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer	2
First-Line Therapy for Chronic Lymphocytic Leukemia	2
Initial and Consolidation Therapy for Younger Patients with Mantle Cell Lymphoma	2
Is Limited-Stage Mantle Cell Lymphoma Curable and How Is It Best Managed?	2
The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies	2
Biology and Treatment of HER2-Low Breast Cancer	2
Management of Peritoneal Disease in Colorectal Cancer	2
Prognostic and Predictive Implications of Cytogenetics and Genomics	2
Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma	2
Complications of Autoimmune Hemolytic Anemia	2
Breast Cancer and Lifestyle Factors	2
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma	2
Where Does Morphology Fit in Myelodysplastic Syndrome Diagnosis in the Era of Molecular Testing?	2
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer	2
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer	2
Renal Involvement in Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	2
Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma	2
Advancing Effective Clinical Trial Designs for Myelofibrosis	2
Adjuvant Therapy of Melanoma	2
Pathogenic Mechanisms in Thalassemia I	2
Radiologic Evaluation of the Head and Neck Cancer Patient	2
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	2
The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes	2
Radiotherapy for Pancreatic Adenocarcinoma	2
Novel Agents in Waldenström Macroglobulinemia	2
What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?	2
Genetics of Pancreatic Neuroendocrine Tumors	2
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology	2
The Gut Microbiome in Colorectal Cancer	2
Allogeneic Transplant and Gene Therapy	2
Current Perioperative Therapy for Muscle Invasive Bladder Cancer	2
Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care	2
Immunomodulatory Agents in Follicular Lymphoma	2
Blastic Plasmacytoid Dendritic Cell Neoplasm	2
Early Progression of Follicular Lymphoma	2
Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers	2
Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer	2
Hereditary Renal Cell Carcinoma Syndromes	2
The Cardiopulmonary Complications of Sickle Cell Disease	2
Central Nervous System Complications Among Oncology Patients	2
Adeno-Associated Virus Vector Design–Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle	2
Cytotoxic Chemotherapy in Advanced Pancreatic Cancer	2
Genomics of Resistance to Targeted Therapies	1
Nonsurgical Therapy for Early-Stage Lung Cancer	1
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia	1
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia	1
State of the Art of Pathologic and Molecular Testing	1
What Causes Bruton Tyrosine Kinase Inhibitor Resistance in Mantle Cell Lymphoma and How Should We Treat Such Patients?	1
Inherited Platelet Disorders	1
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	1
Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia	1
Toward a Cure for Follicular Lymphoma	1
Genotyping and the Future of Transfusion in Sickle Cell Disease	1
Role of Surgery in Metastatic Renal Cell Carcinoma	1
Breast Cancer Pathology in the Era of Genomics	1
Phosphatidylinositol-3-Kinase Inhibition in Follicular Lymphoma	1
Unmet Need in Essential Thrombocythemia and Polycythemia Vera	1
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	1
Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and Beyond	1
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	1
Evaluation and Management of Bing–Neel Syndrome	1
Approach to the Patient with Bleeding	1
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors	1
Renal Cell Cancer	1
First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma	1
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies	1
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	1
More Drugs Versus More Data: The Tug of War on Cancer in Low- and Middle-Income Countries	1
Central Nervous System Tumor Classification	1
New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia: Traditional and Novel Tests	1
Disparities in Breast Cancer Outcomes and How to Resolve Them	1
Surgical Management of Localized Disease and Small Renal Masses	1
Laboratory Methods in the Assessment of Hereditary Hemostatic Disorders	1
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	1
Understanding Health-Related Quality of Life in Patients with Mantle Cell Lymphoma	1
Cellular Therapy in Follicular Lymphoma	1
New Therapies on the Horizon	1
Immunotherapy for Colorectal Cancer	1
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors	1
Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma	1
Genes as Medicine	1
Advances in Surgical Techniques for Lung Cancer	1
Thalassemia	1
Introduction to the Thalassemia Syndromes	1
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia	1
Sickle Cell Disease and the Kidney	1
Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia	1
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia	1
Important Pathologic Considerations for Establishing the Diagnosis of Myelofibrosis	1
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease	1
Peripheral Nervous System Involvement	1
New Insights into Adjuvant Therapy for Localized Colon Cancer	1
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	1